Sci-Group – The Future of Cryopreservation

Sci-Group has developed a groundbreaking freezing technology that enables safe and efficient cryopreservation of cells and tissues—completely without the use of cytotoxic chemical cryoprotectants such as DMSO.

What is cryopreservation?

Cryopreservation is the process of freezing living cells or tissues to extremely low temperatures to halt all biological activity and preserve them for the future. Traditionally, this has required the use of chemical cryoprotectants such as DMSO, but these substances can be cytotoxic and present clinical, technical, and regulatory challenges.

Challenges with traditional methods

The current standard for cryopreservation often involves the use of DMSO, which can cause side effects in patients, reduce cell viability, and complicate handling. Strict regulatory requirements and the need for extensive washing and quality control make the process time-consuming and costly.

Sci-Group’s solution: CryoEmbla

Sci-Group has developed CryoEmbla—a patented freezing technology that freezes cells quickly and precisely, without the need for DMSO or other cytotoxic chemical cryoprotectants. The result is demonstrated cell viability, a simplified workflow, and a solution that supports safer use for both research and clinical applications.

Key advantages:

• No cytotoxic chemical cryoprotectants: No need for DMSO or other cytotoxic additives.
• Faster freezing: From several hours to just minutes.
• Maintains cell viability: Demonstrated cell survival after thawing—even for sensitive cell types.
• Easier handling: Less washing required and fewer sources of error.
• Supports safer clinical use: Reduces the risk of cytotoxic exposure for patients and may simplify regulatory processes.

Areas of application

This technology opens new opportunities within:
– Medicine and healthcare (cell and gene therapy, IVF, tissue preservation)
– Research and biobanking
– Biotechnology and pharmaceuticals
– Agriculture and food security
– Conservation and biodiversity

Market and growth

The demand for safe, effective, and cytotoxic chemical-free solutions is increasing globally. Sci-Group has already completed successful pilot projects, entered into strategic partnerships, and received significant interest from leading institutions. The cryopreservation market is growing rapidly, and CryoEmbla gives Sci-Group a unique position internationally.

Want to know more?

Contact our team for access to updated materials and market data.